This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q04.3 | Special Copayment Reduction: V214 |
| B. Synonyms | Lissencephaly | pachygyria |
| C. Adult onset | Very low — as a congenital malformation of cerebral cortical gyration, it is as a rule diagnosed in the fetal or neonatal period, and first presentation in adulthood is extremely rare. |
| 1. History | First described by Miller in 1970 → 1988 Dobyns, association with the LIS1 gene → 1993 discovery of XLIS (DCX) → molecular classification established in the modern genomic era. |
| 2. Causes | Gene variants (LIS1/PAFAH1B1, DCX, ARX, TUBA1A, etc.), chromosomal abnormalities (17p13.3 deletion), intrauterine infection (CMV), ischemia, idiopathic. |
| 3. Genetics | LIS1 (17p13.3) autosomal dominant/deletion; DCX (Xq22.3) X-linked; tubulin family genes such as TUBA1A, TUBB2B, DYNC1H1; mostly de novo mutations. |
| 4. General epidemiology | 11.7 per about 100,000 births (complete lissencephaly); no sex predilection; a rare malformation worldwide. |
| 5. Pathophysiology | Cerebral cortical neuronal migration failure; neurons fail to migrate from the medial cerebral zone to the cortical surface → inability to form cortical gyri. |
| 6. Symptoms | Severe intellectual disability, seizures (infantile spasms, Lennox-Gastaut syndrome), hypotonia or hypertonia, developmental arrest, feeding disorders. |
| 7. Signs | Macrocephaly or microcephaly, absence of cerebral gyri (MRI), abnormal muscle tone, nystagmus, EEG abnormalities (hypsarrhythmia). |
| 8. Screening | Prenatal ultrasound (limited assessment of gyration after 20 weeks); fetal MRI (useful after 28 weeks of gestation); prenatal gene panel. |
| 9. Diagnosis | Brain MRI (absent or simplified gyri, thick cortex); gene panel/WES/WGS; chromosomal microarray. |
| 10. Treatment | No curative treatment; anticonvulsants (infantile spasms: ACTH, vigabatrin), tube feeding, rehabilitation, respiratory support. |
| 11. Prognosis | Severe prognosis; most patients with complete lissencephaly die before age 10; pachygyria varies in severity, with some surviving into adulthood. |
| 12. Prevention | Prenatal genetic counseling, preimplantation genetic testing (PGT), CMV prevention, prevention of infection during pregnancy. |
| 13. References | Dobyns WB et al. 1993 and 9 other references |
Lissencephaly (a state in which the brain surface is smooth and without gyri) and pachygyria (a state in which the gyri are broad and simplified) are congenital brain malformations caused by a neuronal migration disorder of the cerebral cortex, and together they form the spectrum of "gyration defects." The first systematic descriptions of this disease were made by Miller in 1970 and Dieker in 1963. Miller-Dieker syndrome (MDS) is a syndrome with severe lissencephaly and characteristic facial dysmorphism due to a chromosome 17p13.3 deletion, and it became the basis for the first molecularly based classification of lissencephaly.
In 1988, William B. Dobyns presented the first systematic classification of lissencephaly and specified the 17p13.3 location of the LIS1 (now PAFAH1B1) gene. In 1993, Dobyns and his collaborators mapped the DCX (doublecortin) gene, associated with X-linked lissencephaly, to Xq22.3; this gene drew attention for its unique sex-specific phenotype, causing lissencephaly in boys and double cortex syndrome (subcortical band heterotopia) in girls. Since the 2000s, as variants in various tubulin and dynein family genes such as TUBA1A, TUBB2B, TUBB3, and DYNC1H1 were found to be associated with lissencephaly and related cortical migration disorders, molecular classification and understanding of phenotype–genotype correlations advanced rapidly.
In Korea, too, since the 2010s, as next-generation sequencing (NGS)-based gene panel testing has spread into clinical practice, the rate of identifying the molecular cause of lissencephaly/pachygyria has increased, and with advances in fetal MRI technology, the number of cases that can be diagnosed prenatally is increasing. This disease can currently be registered under Special Copayment Reduction code V214 to receive medical cost support.
The causes of lissencephaly/pachygyria are broadly divided into genetic causes, intrauterine environmental factors, and idiopathic. Genetic causes are the most important, and to date variants in more than 20 genes are known to be associated with this spectrum.
LIS1/PAFAH1B1 gene variants: heterozygous deletions or point mutations of the LIS1 (platelet-activating factor acetylhydrolase 1B regulatory subunit, PAFAH1B1) gene on chromosome 17p13.3 are the most common genetic cause. The LIS1 protein is a microtubule-associated protein (regulator of the dynein complex) essential for intracellular neuronal migration, and with loss of function, the migration of neurons from the inner region to the cortical surface is severely impaired. Miller-Dieker syndrome is due to a large 17p13.3 deletion that includes LIS1, accompanied by severe lissencephaly, characteristic facial dysmorphism (high forehead, flat nasal bridge, small mouth), cardiac malformations, and more.
DCX (doublecortin) gene variants: the DCX gene, located on the long arm of the X chromosome (Xq22.3), encodes a protein involved in microtubule polymerization. In males (hemizygous), DCX variants cause severe lissencephaly, and in females (heterozygous) they show a unique phenotype called subcortical band heterotopia (double cortex syndrome). In this condition, only some neurons migrate, forming a layer of heterotopic neurons between the normal cortex and the white matter.
Tubulin family gene variants: variants in alpha- and beta-tubulin genes such as TUBA1A (2q31.1), TUBB2B (6p25.2), and TUBB3 (16q24.3) cause complex cortical migration disorders including lissencephaly, pachygyria, cerebellar hypoplasia, corpus callosum abnormalities, and brainstem dysplasia. Most of these variants arise de novo, and phenotypic heterogeneity is great.
Intrauterine environmental factors: cytomegalovirus (CMV) infection during pregnancy can cause various brain malformations, including neuronal migration disorders. Intrauterine ischemia, toxic exposures (alcohol, cocaine), and radiation exposure have also been reported as risk factors.
Lissencephaly/pachygyria is a genetically very heterogeneous group of disorders, and autosomal dominant, X-linked, and autosomal recessive modes of inheritance have all been reported. The most common pattern is sporadic occurrence due to de novo mutations.
LIS1/PAFAH1B1 (17p13.3): autosomal dominant inheritance or deletion. A 17p13.3 microdeletion is characteristic of Miller-Dieker syndrome, which means simultaneous loss of not only LIS1 but also adjacent genes. Isolated LIS1 variants also cause lissencephaly. In both cases, most arise as de novo mutations, but familial recurrence due to germline mosaicism has been reported.
DCX (Xq22.3): X-linked inheritance. Hemizygous mutations in boys cause severe lissencephaly, and heterozygous mutations in girls cause double cortex syndrome (mild intellectual disability and seizures). Female carriers may have mild or no symptoms, delaying diagnosis.
ARX (Xp21.3): X-linked inheritance. In boys, it causes XLAG syndrome (X-linked lissencephaly with abnormal genitalia), accompanied by lissencephaly, agenesis of the corpus callosum, and abnormal genitalia.
Tubulin gene family: TUBA1A, TUBB2B, TUBB3, TUBG1, DYNC1H1, KIF2A, etc. Mostly autosomal dominant de novo mutations. Phenotypes range widely from lissencephaly to pachygyria, cerebellar hypoplasia, and brainstem dysplasia. Even within the same gene, phenotypes vary with the location and type of variant.
Molecular genetic confirmation is essential for genetic counseling. Parental testing assesses whether the mutation is de novo and the possibility of germline mosaicism, and on this basis the recurrence risk for the next pregnancy is provided (generally <1~5% for de novo mutations, up to ~20% when germline mosaicism is present).
Lissencephaly/pachygyria is a congenital malformation due to cerebral cortical neuronal migration disorder and occurs rarely worldwide. The incidence of complete lissencephaly (lissencephaly grade I-II) is estimated at about 1 in 85,000~100,000 births, and some literature reports an incidence of 11.7 per 100,000 births. When the broad spectrum including pachygyria and subcortical band heterotopia is considered as a whole, the frequency becomes higher.
Regarding sex distribution, LIS1 variants occur equally in males and females, while DCX variants show a sex-specific phenotype in which complete lissencephaly occurs in hemizygous boys and double cortex syndrome in heterozygous girls. Therefore, clinically, different phenotypes may appear by sex even within the same family, so care is needed in diagnosis. No ethnic or regional predominance has been reported, and it occurs in all populations worldwide.
In Korea, rare disease registration data suggest that dozens of new diagnoses are made each year, and patients can be registered under Special Copayment Reduction code V214 to receive medical cost support. It should be included in the differential diagnosis of every infant with congenital microcephaly, infantile spasms, or severe intellectual disability. With the spread of fetal MRI, the prenatal diagnosis rate is gradually rising, and assessment of cerebral gyration becomes more accurate after 28 weeks of gestation.
The core pathogenic mechanism of lissencephaly/pachygyria is cortical neuronal migration failure. Normally, cerebral cortical neurons are generated between 7 and 20 weeks of gestation in the germinal zones around the ventricles, especially the subventricular zone (SVZ) and ventricular zone (VZ), and then migrate to the cortical surface along the processes of radial glia. This process requires precise coordination of microtubule dynamics and microtubule-associated proteins (LIS1/dynein complex, doublecortin, tubulin isotypes, etc.).
Disruption of the LIS1/dynein pathway: the LIS1 protein is a regulator of the cytoplasmic dynein complex and is essential for nuclear translocation, the process in which the nucleus advances in the direction of neuronal migration. With loss of LIS1 function, nuclear translocation is impaired, so neurons cannot migrate along the radial glial processes and remain in intermediate positions. As a result, the cortex is simplified into 4 layers (normally 6 layers) or an undifferentiated structure, and formation of gyri and sulci on the brain surface is completely lost (lissencephaly) or greatly simplified (pachygyria).
DCX/doublecortin pathway: the DCX protein binds to and stabilizes polymerizing microtubules and regulates microtubule organization of the leading process during neuronal migration. With loss of DCX function, neuronal migration is completely blocked in boys, causing lissencephaly, while in girls only some neurons fail to migrate, resulting in double cortex syndrome with a layer of heterotopic neurons formed beneath the cortex. This sex difference arises because, in girls, DCX expression from the normal X chromosome compensates for migration in some neurons.
Tubulin pathway: tubulin gene variants (TUBA1A, etc.) disrupt the process structure of radial glia and microtubule assembly itself, causing neurons to lose the scaffold needed for migration. This also affects cerebellar and brainstem development, accompanied by extensive hindbrain malformations.
Significance of cortical gyration: cerebral gyration begins in earnest in late pregnancy (after 24~28 weeks) and is a process that dramatically expands the cortical surface area. In lissencephaly, no gyri are formed at all, so the brain surface is smooth, and the cortical thickness is abnormally increased to 8~10 mm (normal 3~4 mm). The cortical laminar structure is also simplified to 4 layers or fewer instead of the normal 6. These cortical structural abnormalities are the direct cause of severe intellectual disability, seizures, and motor disorders.
The clinical symptoms of lissencephaly/pachygyria vary with the severity of the gyration abnormality and the extent of associated malformations, but most patients show severe neurodevelopmental disability. Complete lissencephaly shows the most severe clinical course, and pachygyria ranges from mild to severe depending on the extent and degree of the lesions.
Developmental disability: severe intellectual disability (IQ < 20 level) and developmental arrest occur in almost all patients with complete lissencephaly. Most patients do not progress beyond head control or, at best, remain at a developmental level of 3~5 months. They fail to achieve most motor developmental milestones such as sitting, standing, and walking. Communication ability (language) barely develops, and interaction is very limited.
Seizures: seizures occur in almost all patients, and treatment-resistant (drug-refractory) seizures are characteristic. Onset is usually within the first 6 months of life, and infantile spasms (West syndrome) are the most common initial seizure type. They subsequently progress to various types such as Lennox-Gastaut syndrome, myoclonic seizures, tonic-clonic seizures, and atonic seizures. On electroencephalography (EEG), high-voltage hypsarrhythmia, high-voltage slow waves, or multifocal slow-wave complexes characteristically appear.
Abnormal muscle tone: in early infancy, generalized hypotonia is common, and later quadriplegia or spastic abnormalities with flexor spasticity of the upper limbs and extensor spasticity of the lower limbs may appear. Dysphagia and aspiration are frequent, and the resulting pneumonia is a major complication.
Feeding disorders: feeding difficulties due to reduced oral motor function appear from infancy, and nasogastric tube feeding or gastrostomy is often required.
Pachygyria: when lesions are focal or gyral simplification is mild, symptoms range from mild to moderate, with developmental delay and seizures as the main problems, and some patients are capable of independent walking and basic verbal communication.
Findings characteristic of lissencephaly/pachygyria appear on physical examination and neuroimaging.
Head findings: head circumference at birth is often normal or mildly microcephalic, but in Miller-Dieker syndrome associated with LIS1 variants, characteristic facial dysmorphism (sloping forehead, flat nasal bridge, small mouth, thick upper lip, ear abnormalities) is present. Later, microcephaly often develops as head circumference becomes smaller than that of peers with growth.
Neurological signs: hypotonia (floppy infant), later limb spasticity, hyperactive deep tendon reflexes, and a positive Babinski reflex appear. Eye movement abnormalities (lack of visual fixation, strabismus) and nystagmus may be observed. During seizures, the characteristic posture of infantile spasms (sudden flexion-extension movements of the limbs) is observed.
Brain MRI findings: absence of gyri (complete lissencephaly) or simplification (pachygyria). Increased cortical thickness (8~20 mm, normal 3~4 mm). Accompanying agenesis or hypoplasia of the corpus callosum (about 50%). Accompanying cerebellar hypoplasia (common with tubulin gene variants). Ventricular enlargement (colpocephaly due to corpus callosum abnormality). A "figure-of-8" brain cross-section (the distinctive brain outline of lissencephaly) is characteristic.
Electroencephalography (EEG) findings: high-voltage hypsarrhythmia (characteristic in infantile spasms), high-amplitude alpha/beta activity, 2~4 Hz high-voltage rhythms, multifocal slow-wave complexes, etc. are observed. These findings appear almost universally in lissencephaly.
Population-wide screening for lissencephaly/pachygyria is not performed. However, prenatal ultrasound and fetal MRI are used as important prenatal screening and diagnostic tools.
Prenatal ultrasound: cerebral gyration of the fetal head is assessed on detailed ultrasound at 20~22 weeks of gestation. However, because gyration normally begins in earnest after 26 weeks of gestation, abnormal findings may be unclear on early ultrasound. Ventricular enlargement (colpocephaly), corpus callosum abnormalities, and microcephaly are indirect findings raising suspicion of lissencephaly.
Fetal MRI: when a brain abnormality is suspected on prenatal ultrasound, fetal MRI is additionally performed. Gyration abnormalities can be assessed on fetal MRI after 28 weeks of gestation, and its higher resolution than ultrasound is advantageous for detecting associated malformations such as corpus callosum abnormalities and cerebellar hypoplasia. Diagnosing lissencephaly on fetal MRI before 24~26 weeks of gestation is difficult because of the difficulty of distinguishing it from the normal immature brain.
Screening of high-risk groups: when there was a child with lissencephaly in a previous pregnancy, when one of the parents is a woman with double cortex syndrome (DCX variant), or when a parent is a carrier of a known genetic variant, prenatal genetic testing (direct variant analysis of fetal DNA) is performed together with genetic counseling. Preimplantation genetic testing (PGT) may also be considered in high-risk families.
Confirmation of lissencephaly/pachygyria is based on characteristic brain MRI findings, and the causative gene is identified by molecular genetic testing.
Brain MRI: the diagnostic standard; complete absence of cerebral gyri (lissencephaly) or simplified broad gyri (pachygyria) on T1- and T2-weighted images is characteristic. Cortical thickness is increased to 8~20 mm, 2~5 times thicker than normal (3~4 mm). Medially enlarged ventricles (colpocephaly), corpus callosum abnormalities, and cerebellar hypoplasia may appear as accompanying findings. The "figure-of-8" cross-section is a finding specific to lissencephaly. MRI severity grading (grades 1~6, Dobyns classification) is useful for predicting prognosis.
Genetic testing: after confirming the brain MRI findings, stepwise genetic testing is performed to search for the molecular cause. First, LIS1 FISH or MLPA and DCX sequencing are performed; if negative, a lissencephaly/neuronal migration disorder gene NGS panel (including TUBA1A, TUBB2B, ARX, DYNC1H1, etc.) is performed. If this is also negative, whole-exome sequencing (WES) or whole-genome sequencing (WGS) is considered. Chromosomal microarray (CMA) is essential for detecting microdeletions such as Miller-Dieker syndrome.
Electroencephalography (EEG): essential for diagnosing seizures and selecting anticonvulsants. Characteristic findings such as high-amplitude hypsarrhythmia and multifocal slow-wave complexes are assessed. When infantile spasms (West syndrome) are suspected, prolonged video-EEG monitoring is important for diagnosis.
There is currently no fundamental treatment for the cause of lissencephaly/pachygyria, and all treatment aims at symptom control and improving quality of life.
Seizure treatment: for infantile spasms (West syndrome), ACTH (adrenocorticotropic hormone) or vigabatrin is recommended as first-line treatment. Thereafter, depending on seizure type, valproate, levetiracetam, clonazepam, felbamate, rufinamide, and others are used. For drug-refractory seizures, the ketogenic diet is reported to be effective as an adjunct. When seizure control is insufficient, safety education about the risk of seizure-related injury is needed.
Nutritional and feeding support: when there is dysphagia and risk of aspiration, nasogastric tube feeding or gastrostomy (gastrostomy tube, G-tube) is the standard method of long-term nutrition. Safe oral intake is maximized through the cooperation of dietitians, speech therapists, and occupational therapists.
Rehabilitation: physical therapy aims to manage abnormal muscle tone, prevent joint contractures, and improve motor function where possible. Occupational therapy supports activities of daily living and the use of assistive devices. Speech therapy aims to improve communication, including the introduction of augmentative and alternative communication (AAC). Early intervention is known to be important for long-term functional prognosis.
Multidisciplinary management: a multidisciplinary approach involving pediatric neurology, developmental pediatrics, rehabilitation medicine, nutrition, speech therapy, occupational therapy, physical therapy, pulmonology (management of aspiration pneumonia), and medical genetics is needed. Early involvement of a palliative care team is important for family support.
The prognosis of lissencephaly/pachygyria differs greatly depending on the severity of the gyration abnormality, associated malformations, and whether seizures are controlled. Overall, severe neurodevelopmental disability and early death are characteristic, but mild cases of pachygyria show a relatively favorable prognosis.
Mortality and life expectancy: most patients with complete lissencephaly (grades 1~2) die before age 10, and the main causes of death are aspiration pneumonia, respiratory failure, and treatment-resistant seizures. In Miller-Dieker syndrome, mean survival is reported to range from 6~12 months to several years. In patients with an LIS1 variant alone (isolated, not syndromic), mean survival is about 10 years, and some survive longer. In boys with DCX variants, symptom severity varies, and some survive into their teens.
Prognosis of pachygyria: when gyral simplification is focal or mild, mild to moderate intellectual disability and seizures are the main problems, and some patients show a relatively stable clinical course with appropriate anticonvulsant treatment. Patients with mild pachygyria who are capable of independent walking and basic verbal communication can survive into adulthood.
Prognostic factors: brain MRI severity grade (Dobyns classification 1~6), presence of accompanying corpus callosum abnormalities and cerebellar hypoplasia, timing of seizure onset and whether seizures are controlled, and the causative gene (differences between LIS1 vs. DCX and tubulin genes) are important for predicting prognosis.
Complete primary prevention of lissencephaly/pachygyria is currently impossible, but partial prevention is possible through management of known risk factors and genetic counseling.
Genetic counseling and preimplantation genetic testing: in families in which the causative gene has been identified, the recurrence risk is clearly explained through genetic counseling, and implantation of affected embryos can be prevented through preimplantation genetic testing (PGT). This is particularly important for female carriers of DCX variants (double cortex syndrome), because the risk of lissencephaly recurring in a boy in the next pregnancy is 50%.
CMV prevention: to prevent cytomegalovirus (CMV) infection during pregnancy, hygiene rules such as hand washing, hygiene after contact with infants' diapers, and use of CMV-negative blood products are followed. CMV serological testing of pregnant women and checking for primary infection are also considered.
Prenatal care: folic acid supplementation before pregnancy, abstinence from alcohol during pregnancy, avoidance of teratogenic drugs, and control of maternal diabetes are recommended. Early detection is achieved through detailed prenatal ultrasound and fetal MRI, and pregnancy management proceeds with genetic counseling and the support of a multidisciplinary fetal medicine team.